Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Xspray Pharma AB ( (SE:XSPRAY) ) just unveiled an announcement.
Xspray Pharma AB has called its shareholders to an annual general meeting in Stockholm on 12 May 2026, outlining how investors can participate either in person, by proxy or through advance voting. The notice details registration deadlines, procedures for nominee-registered shareholders, and confirms that the company has 41,742,340 shares outstanding with one vote per share and no treasury stock.
The agenda for the meeting covers standard governance items including election of the meeting chairman, approval of the agenda and voting register, verification that the meeting is duly convened, and presentation of the annual and auditor’s reports. Shareholders will also vote on adoption of the income statement and balance sheet and on the allocation of the company’s profit or loss, decisions that may influence future capital structure and dividend policy considerations.
The most recent analyst rating on (SE:XSPRAY) stock is a Hold with a SEK29.00 price target. To see the full list of analyst forecasts on Xspray Pharma AB stock, see the SE:XSPRAY Stock Forecast page.
More about Xspray Pharma AB
Xspray Pharma AB is a Sweden-based pharmaceutical company focused on developing improved versions of existing cancer therapies using its proprietary technology platforms. The company targets oncology treatments where optimized formulations can offer patients better dosing, stability or bioavailability, aiming to strengthen its position in the specialty pharma segment.
Average Trading Volume: 51,164
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.21B
For a thorough assessment of XSPRAY stock, go to TipRanks’ Stock Analysis page.